Peer Review History
| Original SubmissionDecember 7, 2021 |
|---|
|
PONE-D-21-38754Inactivation of SARS-CoV-2 and influenza A virus by spraying hypochlorous acid solution and hydrogen peroxide solution in the form of Dry FogPLOS ONE Dear Dr. Kameoka, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The methodology is important for the criterion of PLOS ONE. Please pay a special attention to the methods. Please submit your revised manuscript by Feb 26 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Etsuro Ito Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: "This work was supported in part by a research fund from H. Ikeuchi & Co. for the industry-academia joint research project (for M.U., A.K., T.K., K.S., Y.M. and M.K.); a research grant by the Kobe University Graduate School of Health Sciences (for M.K.); and a research grant by the Japan Agency for Medical Research and Development (AMED) under grant number JP20nk0101634 (for M.K.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript." We note that one or more of the authors is affiliated with the funding organization, indicating the funder may have had some role in the design, data collection, analysis or preparation of your manuscript for publication; in other words, the funder played an indirect role through the participation of the co-authors. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please do the following: a. Review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. These amendments should be made in the online form. b. Confirm in your cover letter that you agree with the following statement, and we will change the online submission form on your behalf: “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In title and throughout paper, the term “dry fog” does not need to be capitalized, since it is not a proper noun. this may be an issue with English Line 21: you should clarify that the current thinking is that the predominant mechanism for transmission is via air (small particles, up to droplets), but that contact with contaminated surfaces may be a possibility. 57: confusing “spraying” for “fogging” they are not the same. 59-63: the sentence is a bit long, and somewhat inaccurate. Check the reference again, but after looking at it myself, it seems the CDC is ok with spraying, and using some types of foggers. Maybe the authors are confusing fogging with spraying, due to English being their second language. 65: change “spraying” to “dispensing”… this comment applies throughout the paper. 67: add reference for your dry fog definition. 85: indicate how pH was measured 118: suggest starting a new paragraph here in discussing inoculation of the viruses into the well plates. Also need to add some more details about this. For example, need to address how were the viruses added, how many well plates were inoculated with virus each experiment, how the positive controls were handled, etc. 130: so a sprayer was used and not a fogger? It’s confusing. 136: explain what the 4 petri plates of water were used for 162: what is DPD? Confirm that the chlorine meter measures free available chlorine and not just other species of chlorine 169: indicate what was used to measure temp and relative humidity 170-180: the paragraph about how the experiments were conducted is not very clear. 171: need to clarify how many viral samples were resuspended with the DMEM/neutralizer. I’m assuming maybe ¼ of samples were treated this way… and then another ¼ after each 4 minute dwell time? Please fix this. 174: are the concentrations of the disinfectants from the petri dishes reported anywhere, and how do they compare to what was spread? 189-210: I’m not sure it is scientifically correct to report the data as a function of time, since what you’re really doing is increasing dose or mass over time. If you had fogged the chamber one time, then taken samples after that at discrete time points, then it would be ok to report inactivation as a function of time. But you have the two variables (time and mass of disinfectant dispensed or dose) intertwined. 212: regarding this subsection, that you would get increased mass of disinfectant over cumulative time seems a bit obvious, so authors need to clarify what is new about this. 241: you should indicate here what the inactivation rates are, instead of just saying they are derived from the slopes. 253: clarify what you mean by viral solutions differed by physiological conditions 258: as mentioned before, be careful about using the word kinetics (implying rate over time), since it’s also about inactivation as a function of mass applied or dose. 268: PAA is always in equilibrium with hydrogen peroxide. 1st paragraph in Discussion: The authors need to clarify what was new/significant about their research. If no one has looked at using fogging of hydrogen peroxide or hypochlorous acid to inactivate SARS CoV 2 or influenza, then state this. If there have been studies looking at that, then you need to reference those and further differentiate your study from them. 269: if dry fogging is considered to be effective based on previous research, then explain why the current study was conducted. This sentence needs some work. 272: rather than say they won’t remain in the environment, you should discuss their reaction byproducts and how long those will remain in the environment. HP decays to water and O2, but what about HOCl? 272: again, to reiterate throughout the article, you need to differentiate between spraying and fogging. They are not the same. 277-278: do those studies compare influenza and SARS CoV-2 stability? If not, then referencing them doesn’t really help here with respect to saying they’re consistent or not with your study. 279: you need to clarify that to effectively inactivate both the flu and SARS virus using a similar contact time, you needed to use a higher concentration of disinfectant for the flu virus. You might have been able to inactivate the flu virus effectively with a lower concentration of disinfectant, but it may have required a longer contact time. 285: indicate whether you saw excessive condensation on the chamber walls when you were doing your experiments. Did opening the chamber door every 4 minutes help to remove condensation? 290: it depends on the drop size if they behave like air. They need to be really small to behave like air 294-299: you may want to clarify that fogging of disinfectant chemicals should be done with no people present in the space. If they have to be present, they should be wearing appropriate PPE and respiratory protection. 300-303: again, this is quite obvious. 316-318: this sentence makes no sense. Please rewrite. 316-328: this paragraph doesn’t really have any relevance to the study. Delete or fix. 343: I think the lipid envelope is one of the more critical physiological factors involved in viral inactivation; you may want to emphasize that more in your discussion. Lipid enveloped viruses are the least resistant microbes to disinfection: https://www.cdc.gov/infectioncontrol/guidelines/disinfection/tables/figure1.html Figure 4: need to indicate the units for Y axis dose for A and B. Also, in Figure 4C and 4D, the X-axis says concentration, but your units say micrograms. Concentration is usually mass/volume. So need to clarify these. 497: at least 3 independent experiments? Or were they replicates? The number of replicates and/or experiments should be explained in the Materials and Methods section General comment about figure legends: They all need to be more concise; they are too long and wordy. For example, no need to refer to and or repeat info already discussed in M and M section. If info about how the data or chart was developed or m Reviewer #2: excellent work, well designed and thought through; see below Line 61: correct the sentence Line 112: specify what method used to calculate TCID50 (Reed-Muench or Spearman-Kaber) Line 128: specify what type of BSC (Class II type A2, Class II type B2, Class III, etc.) Show data demonstrating the effectiveness and/or interference of the neutralizers used to neutralize HAS and H2O2 on viral growth and/or tissue culture Any thoughts on why HAS is more resistant to SARS-CoV-2 (in comparison to Influenza A) while less so against H2O2 Line 295: did you mean, “the amount of air being inhaled by the number of breaths” instead of the amount of suction…” Line 296: consider writing “and the toxicity of the chemical to the human body” Line 311: did you mean “the amount of disinfectant needed for the volume…” Line 496: “n.s. not significant” are you planning to add this in the actual figure? If not, no need for this sentence here ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-38754R1Inactivation of SARS-CoV-2 and influenza A virus by dry fogging hypochlorous acid solution and hydrogen peroxide solutionPLOS ONE Dear Dr. Kameoka, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The comments raised by the reviewer seem minor. Please submit your revised manuscript by Apr 23 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Etsuro Ito Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I think you still need to make the figure captions more concise. A lot of the verbiage in the captions I believe is already described in the materials/methods section, or described in the Results section. I think the Discussion section could be made more concise as well, especially the last two paragraphs. this seems like a repeat of the Introduction. In the abstract and elsewhere, where you say that it is also transmitted by contact infection, i think maybe you should say it may be transmitted by surface contact. Use the word "may". ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Inactivation of SARS-CoV-2 and influenza A virus by dry fogging hypochlorous acid solution and hydrogen peroxide solution PONE-D-21-38754R2 Dear Dr. Kameoka, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Etsuro Ito Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-21-38754R2 Inactivation of SARS-CoV-2 and influenza A virus by dry fogging hypochlorous acid solution and hydrogen peroxide solution Dear Dr. Kameoka: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Etsuro Ito Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .